Display options
Cite
Gelhorn HL, Sexton CC, Classi PM. Patient preferences for treatment of major depressive disorder and the impact on health outcomes: a systematic review. Prim Care Companion CNS Disord. 2011;13(5)doi: 10.4088/PCC.11r01161.
Gelhorn, H. L., Sexton, C. C., & Classi, P. M. (2011). Patient preferences for treatment of major depressive disorder and the impact on health outcomes: a systematic review. The primary care companion for CNS disorders, 13(5), . https://doi.org/10.4088/PCC.11r01161
Gelhorn, Heather L, et al. "Patient preferences for treatment of major depressive disorder and the impact on health outcomes: a systematic review." The primary care companion for CNS disorders vol. 13,5 (2011). doi: https://doi.org/10.4088/PCC.11r01161
Gelhorn HL, Sexton CC, Classi PM. Patient preferences for treatment of major depressive disorder and the impact on health outcomes: a systematic review. Prim Care Companion CNS Disord. 2011;13(5). doi: 10.4088/PCC.11r01161. PMID: 22295273; PMCID: PMC3267514.
Copy Download .nbib Format: NLM
Share it on

Prim Care Companion CNS Disord. 2011;13(5). doi: 10.4088/PCC.11r01161.

Patient preferences for treatment of major depressive disorder and the impact on health outcomes: a systematic review.

The primary care companion for CNS disorders

Heather L Gelhorn, Chris C Sexton, Peter M Classi

Affiliations

  1. United BioSource Corporation, Bethesda, Maryland, USA.

PMID: 22295273 PMCID: PMC3267514 DOI: 10.4088/PCC.11r01161

Abstract

OBJECTIVE: To summarize the peer-reviewed literature on patient preferences for depression treatments and the impact of these preferences on the outcomes of treatment.

DATA SOURCES: Studies were identified via a systematic search conducted simultaneously in PsycINFO and MEDLINE using EBSCOhost and EMBASE. Publications were retrieved in March 2010.

STUDY SELECTION: Search terms included depression OR MDD OR major depressive disorder, patient preference, treatment preference, intervention preference, and pharmacotherapy preference. There were no restrictions on years of publication. The search was restricted to research articles written in English.

DATA EXTRACTION: Fifteen articles contained unique information on patient preferences for depression treatments and their impact on depression-related outcomes.

RESULTS: The patient preference literature includes a limited number of studies examining the impact of patient preferences on outcomes such as depression severity, treatment initiation, persistence and adherence, treatment engagement, the development of the therapeutic alliance, and health-related quality of life. The majority of the preference research has focused on comparisons of psychotherapy versus pharmacotherapy, with some limited information regarding comparisons of psychotherapies. Results from the research to date suggest that the impact of patient treatment preferences is mixed. The results also indicate that patient preferences have minimal impact on depression severity outcomes within the context of controlled clinical trials but may be more strongly associated with other outcomes such as entry into treatment and development of the therapeutic alliance. However, it is important to note that the literature is limited in that the impact of patient preference has been examined only through secondary analyses, and there have been few studies designed explicitly to examine the impact of patient preferences, particularly outside the context of controlled clinical trials.

CONCLUSIONS: Consideration of patient preferences for depression treatments may lead to increased treatment initiation and improved therapeutic alliance. However, despite treatment guidelines and suggestions in the literature, the value of and appropriate procedures for considering patient preferences in real-world treatment decisions deserves more careful study. Further research is needed, and future studies should be conducted in more naturalistic treatment settings that examine patient preferences for other specific approaches to depression treatments including preferences related to comparisons of individual pharmacotherapies and second-step treatments.

References

  1. Arch Gen Psychiatry. 1961 Jun;4:561-71 - PubMed
  2. Ann Behav Med. 2005 Oct;30(2):164-73 - PubMed
  3. Am J Psychiatry. 2007 May;164(5):753-60 - PubMed
  4. Behav Ther. 2007 Sep;38(3):209-17 - PubMed
  5. J Adolesc Health. 2007 May;40(5):433-9 - PubMed
  6. Dis Nerv Syst. 1977 Apr;38(4):249-51 - PubMed
  7. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62 - PubMed
  8. BMC Psychiatry. 2007 Sep 13;7:48 - PubMed
  9. Early Interv Psychiatry. 2007 Nov;1(4):333-9 - PubMed
  10. J Am Coll Health. 1992 Jul;41(1):3-10 - PubMed
  11. Am J Public Health. 2004 Oct;94(10):1782-7 - PubMed
  12. Prim Care Companion J Clin Psychiatry. 2001 Dec;3(6):232-235 - PubMed
  13. Med Care. 2001 Sep;39(9):934-44 - PubMed
  14. Arch Gen Psychiatry. 1978 Jun;35(6):773-82 - PubMed
  15. Int J Psychiatry Clin Pract. 2008;12(1):5-10 - PubMed
  16. Br J Gen Pract. 2000 Nov;50(460):905-6 - PubMed
  17. J Consult Clin Psychol. 2007 Feb;75(1):194-8 - PubMed
  18. Am J Orthopsychiatry. 2007 Apr;77(2):231-242 - PubMed
  19. Arch Gen Psychiatry. 1998 Dec;55(12):1121-7 - PubMed
  20. CNS Spectr. 2007 Aug;12(8 Suppl 13):1-27 - PubMed
  21. J Gen Intern Med. 2001 Dec;16(12):793-9 - PubMed
  22. J Affect Disord. 2006 Feb;90(2-3):217-21 - PubMed
  23. J Adolesc Health. 2009 Jun;44(6):546-53 - PubMed
  24. BMJ. 2000 Dec 2;321(7273):1383-8 - PubMed
  25. BMJ. 1989 Jul 29;299(6694):313-5 - PubMed
  26. Soc Psychiatry Psychiatr Epidemiol. 2007 Mar;42(3):244-50 - PubMed
  27. Am Psychol. 2006 May-Jun;61(4):271-85 - PubMed
  28. Psychother Res. 2009 Mar;19(2):205-12 - PubMed
  29. Swiss Med Wkly. 2006 Feb 4;136(5-6):78-85 - PubMed
  30. Med Care. 2000 Mar;38(3):335-41 - PubMed
  31. Int J Psychiatry Clin Pract. 2009;13(2):109-16 - PubMed
  32. J Gen Intern Med. 2006 Feb;21(2):146-51 - PubMed
  33. Adm Policy Ment Health. 2006 Mar;33(2):198-207 - PubMed
  34. Br J Psychiatry. 2000 Oct;177:312-8 - PubMed
  35. Psychosomatics. 2007 Nov-Dec;48(6):482-8 - PubMed
  36. Health Technol Assess. 2000;4(19):1-83 - PubMed
  37. Prim Care Companion J Clin Psychiatry. 2000 Dec;2(6):211-216 - PubMed
  38. Drugs Aging. 2007;24(10):801-14 - PubMed
  39. J Ment Health Policy Econ. 2007 Jun;10(2):73-85 - PubMed
  40. J Clin Psychiatry. 2009 Jun;70(6):e18 - PubMed
  41. BMJ. 2001 Mar 31;322(7289):772-5 - PubMed
  42. Arch Gen Psychiatry. 2005 May;62(5):513-20 - PubMed
  43. Med Care. 1992 Jun;30(6):473-83 - PubMed
  44. Int J Geriatr Psychiatry. 2007 Nov;22(11):1141-6 - PubMed
  45. Gen Hosp Psychiatry. 2006 Sep-Oct;28(5):379-86 - PubMed
  46. J Clin Psychiatry. 2009 Mar;70(3):354-61 - PubMed
  47. Gerontologist. 2006 Feb;46(1):14-22 - PubMed
  48. J Am Acad Nurse Pract. 2009 Jul;21(7):362-70 - PubMed
  49. Gen Hosp Psychiatry. 2007 May-Jun;29(3):182-91 - PubMed
  50. Psychiatr Serv. 2009 Mar;60(3):337-43 - PubMed
  51. J Gen Intern Med. 2000 Aug;15(8):527-34 - PubMed
  52. J Clin Psychiatry. 2009;70 Suppl 6:16-25 - PubMed

Publication Types